Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
NCT03371758 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-01-23
Summary
The exact mechanism of impairment of autophagy in vitiligo has not yet been determined.
Conditions
- Autophagy
Interventions
- OTHER
-
skin biopsy
Punch skin biopsy will be taken from the lesional and non-lesional skin of vitiligo patients as well as healthy skin of controls.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2018-05-31
- Completion
- 2018-05-31
Countries
- Egypt
Study Locations
More Related Trials
-
Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo
NCT06410898 ·Status: RECRUITING ·Phase: NA
-
Janus Kinase 1 in Vitiligo & Psoriasis
NCT03762551 ·Status: COMPLETED ·Phase: NA
-
Leucotrichia in Vitiligo
NCT03402633 ·Status: COMPLETED
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
Evaluation of Scanoskin for the Assessment of Vitiligo
NCT03133871 ·Status: COMPLETED
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
NCT01459055 ·Status: UNKNOWN
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
NCT07187882 ·Status: RECRUITING ·Phase: NA
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Human Beta-defensin 1 in Vitiligo
NCT03832751 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo
NCT04320160 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Serological Markers of Vitiligo Activity
NCT06731283 ·Status: ACTIVE_NOT_RECRUITING
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Cutaneous JAK in Vitiligo and Acne Vulgaris.
NCT03185312 ·Status: UNKNOWN
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
E-cadherin and Integrin Alpha v Beta 1 in Vitiligo
NCT05287776 ·Status: UNKNOWN ·Phase: NA
-
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
NCT01511965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
Study of in Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis
NCT05312073 ·Status: COMPLETED ·Phase: NA
-
Stress Response Pathways in Vitiligo
NCT02797574 ·Status: COMPLETED ·Phase: NA